1401 related articles for article (PubMed ID: 19458054)
1. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
2. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
3. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
4. [The feasibility and mechanism of recombinant adenovirus Ad - p 14 ARF in gene therapy of liver cancer].
Song HF; Qian HL; Zhang XY; Liang X; Fu M; Lin C
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):641-5. PubMed ID: 17274365
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
[TBL] [Abstract][Full Text] [Related]
8. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
[TBL] [Abstract][Full Text] [Related]
9. [Research on expression and control of p16 and p21 by wild-type p53 gene in two lung adenocarcinoma cell lines].
Jin Y; Yan CH; Wu Y; Liu Y; Zhang GY; Li P; Fu SB
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):409-12. PubMed ID: 14556194
[TBL] [Abstract][Full Text] [Related]
10. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
11. Consequences of p53 gene expression by adenovirus vector on cell cycle arrest and apoptosis in human aortic vascular smooth muscle cells.
Katayose D; Wersto R; Cowan K; Seth P
Biochem Biophys Res Commun; 1995 Oct; 215(2):446-51. PubMed ID: 7487976
[TBL] [Abstract][Full Text] [Related]
12. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
Dong YB; Yang HL; McMasters KM
Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.
Zhu DE; Höti N; Song Z; Jin L; Wu Z; Wu Q; Wu M
Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917
[TBL] [Abstract][Full Text] [Related]
16. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
[TBL] [Abstract][Full Text] [Related]
18. p53 inhibits adriamycin-induced down-regulation of cyclin D1 expression in human cancer cells.
Shao J; Teraishi F; Katsuda K; Tanaka N; Fujiwara T
Biochem Biophys Res Commun; 2002 Jan; 290(3):1101-7. PubMed ID: 11798189
[TBL] [Abstract][Full Text] [Related]
19. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro.
Roy I; Holle L; Song W; Holle E; Wagner T; Yu X
Anticancer Res; 2002; 22(6A):3185-9. PubMed ID: 12530063
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
